Two years after Canada suspended patent restrictions to allow generics of certain drugs to be made for poor countries, the plan has been called ineffective by the nation's health minister. Tony Clement said the countries for which the AIDS, malaria and tuberculosis generics were intended have failed to sign up for the offer. And only one drugmaker, Apotex, has taken advantage of the Jean Chretien Pledge to Africa Act by developing a generic drug.

Related Summaries